1. We've addressed a number of the issues raised in the previous survey. Please help us make sure we're aware of all issues by completing this new, short, confidential survey. Thank you!
  2. Need help finding a board? Read this post for help

Where is the Dulera COPD approval...

Discussion in 'Merck' started by Anonymous, Feb 1, 2012 at 11:36 AM.

  1. Anonymous

    Anonymous Guest

    that we were supposed to get the last week of January 2012?
     
  2. Anonymous

    Anonymous Guest

    winter freeze.
     
  3. Anonymous

    Anonymous Guest

    Just announced today that it was not approved by the FDA. Check Com Central for the full details of the "Approvable Letter."
     
  4. Anonymous

    Anonymous Guest

    It was NOT approved by the FDA.
     
  5. Anonymous

    Anonymous Guest

    For me, this is unforgivable. Between the Singulair threat and the incompetence of our Leadership in most areas of our business. I am done with Merck. WTF were they doing in the studies....this drug is already a grinder and now this. And they keep spinning it, as if were imbeciles.

    FU MERCK!!!
     
  6. Anonymous

    Anonymous Guest

    2nd time in 2 weeks FDA says FU Merck!
     
  7. Anonymous

    Anonymous Guest

    Ok folks.....seriously, what went wrong with our COPD indication? Why wasn't it granted? Any thoughts out there?
     
  8. Anonymous

    Anonymous Guest

    Does it really matter? Sales may climb from $14 to $16 annually. Who knows, maybe we'll even get a full prescription some day and sales will skyrocket. Who is the one idiot writing this garbage? That's what I'd like to know.
     
  9. Anonymous

    Anonymous Guest

    Bahahahahahahahahahahahahaha
     
  10. Anonymous

    Anonymous Guest

    how about some transparency from the Dulera Marketing Team!!!
     
  11. Anonymous

    Anonymous Guest

    Really what team??? Those over paid loosers can't manage a Dr. Scholls store in India
     
  12. Anonymous

    Anonymous Guest

    Schering incurred wrath of FDA and it has carried over. Losers!
     
  13. Anonymous

    Anonymous Guest

    Look the non-steroidal side of the combo is not the FDA's favorite. The steroidal side of the combo was never a big seller. What part of that combo was going to make a blockbuster. S-P knew that this combo was no great shakes. I don't know what Merck was thinking. Over the last 6 years I must tell you that S-P's reputation with the FDA is far better than Merck's. The number of Old Merck's shocking rejections from the FDA is stunning. Half-baked applications from legacy Merck coupled with not particularly interesting products from S-P and the merge company all adds up to some grim days ahead.
     
  14. Anonymous

    Anonymous Guest


    It might be better but that is not saying much. SP was on their **** list for quite a while. It was what held up Clarinex for quite a while. The FDA figured- why reward a poor performer by giving them the approval when they couldn't even get Proventil to be problem-free. Merck "merged" with this and now we all will pay the price although Merck pays the higher price because they "bought" SP. SP heads will always have a good laugh about this at Merck's expense.
     
  15. Anonymous

    Anonymous Guest

    Bottom line- FDA not happy with us and any form of our company.
     
  16. Anonymous

    Anonymous Guest

    Bottom line...the layoff cuts will be even deeper than expected come April. Get ready to bend over.
     
  17. Anonymous

    Anonymous Guest

    Ain't coming- BS from marketing
     

Share This Page